Top Ten most popular articles on Pharmafile.com this week
October 16, 2020Medical Communications COVID, herd immunity, top ten, top ten articles
The top ten news stories this week focus on herd immunity, as the Director of the World Health Organization has …
80 researchers argue COVID-19 herd immunity strategy is a “dangerous fallacy” in open letter
October 15, 2020Medical Communications, Research and Development, Sales and Marketing COVID-19
A group of 80 researchers have lent their signatures to an open letter published in the The Lancet under the …
Scottish Medicines Consortium gives go-ahead for Novartis’ Mayzent in secondary progressive multiple sclerosis
October 15, 2020Sales and Marketing Mayzent, Novartis, Scotland
Novartis’ Mayzent (siponimod) has been approved by the Scottish Medicines Consortium in the treatment of secondary progressive multiple sclerosis (SPMS) …
NICE recommends siponimod for treating secondary progressive MS
October 15, 2020Medical Communications
The National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending siponimod for treating secondary progressive multiple …
FDA approves Regeneron’s antibody Ebola treatment
October 15, 2020Research and Development Ebola, ebola antibody., ebola treatment
The FDA has approved Regeneron’s antibody drug inmazeb for treating Ebola. The treatment works through targeting the glycoprotein on the …
Russia gives regulatory approval to second COVID-19 vaccine after early clinical trials
October 15, 2020Research and Development COVID Vaccine, Vaccine, coronavirus vaccine
Russian President Vladimir Putin announced on Wednesday that regulators had given approval to a second coronavirus vaccine. This new vaccine …
Scottish Medicines Consortium approves Revlimid for two groups of blood cancer patients
October 14, 2020Research and Development Revlimid, SMC
The Scottish Medicines Consortium (SMC) has accepted Revlimid (lenalidomide) for routine use on NHS Scotland for patients with multiple myeloma …
Eli Lilly COVID-19 antibody therapy trial paused over safety concerns
October 14, 2020Research and Development COVID, Eli Lilly, coronavirus
Eli Lilly has stopped enrolling volunteers in clinical trials of its antibody treatment for the novel coronavirus over safety concerns. …
British man suffers from permanent hearing damage after contracting COVID-19
October 14, 2020Research and Development COVID-19, pharma
A 45-year-old man in the UK has been left with permanent hearing damage after being infected with the novel coronavirus, …
Johnson & Johnson to contribute a further $1 billion to US opioid settlement
October 14, 2020Research and Development, Sales and Marketing J&J, JJ, opioid crisis, opioids, pharma
Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the opioid crisis in the US. …
Pharmafile.com’s weekly COVID-19 news round-up
October 14, 2020Research and Development COVID-19, coronavirus, covid news, pandemic, weekly roundup
The COVID-19 news this week focuses on FDA authorisations, with Eli Lilly seeking Emergency Use Authorization (EUA) from the FDA …
Man in US contracts COVID-19 for the second time with worse symptoms
October 13, 2020Manufacturing and Production COVID, coronavirus
An American man has caught coronavirus for the second time, with the second infection being far more dangerous than the …
J&J halts COVID-19 vaccine study following unidentified participant illness
October 13, 2020Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma
Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …
Head of WHO says herd immunity strategies for COVID-19 are ‘unethical’
October 13, 2020Manufacturing and Production
Tedros Adhanom Ghebreyesus, Director of the World Health Organization, has warned against pursuing a strategy of herd immunity to fight …
Bavencio/axitinib combo approved for NHS Scotland in advanced renal cell carcinoma
October 13, 2020Manufacturing and Production, Sales and Marketing Merck, NHS, Pfizer, SMC
The Scottish Medicines Consortium (SMC) has given the go-ahead to Merck KGaA and Pfizer’s combination of their PD-L1 inhibitor immunotherapy …
UK Government ignored SAGE advice to impose full lockdown last month
October 13, 2020Manufacturing and Production COVID, UK, UK Coronavirus, coronavirus
UK Government ministers ignored warnings three weeks ago that the country should go into a temporary full lockdown to reduce …
University of Glasgow research details promising precision medicine approach in pancreatic cancer
October 12, 2020Research and Development, Sales and Marketing Cancer, Precision Medicine
Researchers at the University of Glasgow have unveiled a new precision medicine approach to identify and pair pancreatic cancer patients …
China to test entire population of Qingdao over nine days
October 12, 2020Sales and Marketing coivd-19, coronavirus, pandemic, virus
China plans to test the entire city of Qingdao, containing nine million people, for coronavirus over a period of five …
Pharmaceutical industry donating more to Democrats than Republicans in the lead up to 2020 election
October 12, 2020Sales and Marketing
The long-term trend of the pharmaceutical industry largely donating to the US Republican Party has been reversed in the lead …
New Zealand Government signs deal with Pfizer and BioNTech for 1.5 million COVID-19 vaccines
October 12, 2020Sales and Marketing
The New Zealand Government has signed a deal with Pfizer and BioNTech for one of their promising COVID-19 vaccine candidates. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
